![Scott Gleason](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Gleason
Directeur Financier/CFO chez
SERA PROGNOSTICS, INC.
Fortune : 240 565 $ au 31/07/2026
Profil
Mr. Scott K.
Gleason is a Chief Financial Officer & Treasurer at Sera Prognostics, Inc. and a Head-Investor Relations at Neogen Corp.
Mr. Gleason was previously employed as a Senior VP-Investor Relations & Communications by OraSure Technologies, Inc., a Senior Vice President-Investor Relations by Myriad Genetics, Inc., and a Research Analyst by Stephens, Inc. He received his undergraduate degree from United States Air Force Academy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/08/2026 | 117 924 ( 0,31% ) | 240 565 $ | 31/07/2026 |
Postes actifs de Scott Gleason
| Sociétés | Poste | Début |
|---|---|---|
| NEOGEN CORPORATION | Investor Relations Contact | - |
| SERA PROGNOSTICS, INC. | Directeur Financier/CFO | 31/08/2026 |
Anciens postes connus de Scott Gleason
| Sociétés | Poste | Fin |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Directeur Financier/CFO | 08/08/2022 |
Stephens, Inc.
 Stephens, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/01/2013 |
| MYRIAD GENETICS, INC. | Investor Relations Contact | - |
Formation de Scott Gleason
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Neogen Corp.
 Neogen Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical testing kits | Health Technology |
Stephens, Inc.
Stephens, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
OraSure Technologies, Inc.
 OraSure Technologies, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, markets and sells oral fluid specimen collection devices | Health Technology |
United States Air Force Academy
 United States Air Force Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sera Prognostics, Inc.
 Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
